TGAN — Transphorm Technology Cashflow Statement
0.000.00%
Last trade - 00:00- $300.95m
- $293.00m
- $16.51m
Annual cashflow statement for Transphorm Technology, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 3 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-KT | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.3 | -17.9 | -6.58 | -10.2 | -30.6 |
| Depreciation | |||||
| Non-Cash Items | 5.2 | 3.74 | 2.79 | -4.39 | 9.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.42 | -0.78 | -1.34 | -5.95 | -6.38 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.3 | -14.1 | -4.93 | -19.7 | -26.5 |
| Capital Expenditures | -0.203 | -0.058 | -0.164 | -0.595 | -6.94 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.7 | -7.35 | -0.968 | -4.53 | -3.21 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.9 | -7.41 | -1.13 | -5.12 | -10.1 |
| Financing Cash Flow Items | — | — | 0.004 | -1.9 | -0.826 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15 | 33.2 | 0.956 | 49.5 | 18.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.194 | 11.8 | -5.19 | 24.4 | -17.9 |